Regencell Bioscience Holdings Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Regencell Bioscience Holdings Limited (RGC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 19.86 thousand shares for the 12-month period ending 2022-06-30, per its 20-F filed 2023-10-27.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2023-10-27
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|
| 2022-06-30 | 19.86K shares 20-F · filed 2023-10-27 |